TrialSite is pleased to report that Francis S. Collins, MD, PhD, and the team at the National Institutes of Health (NIH) will fund a large,…
Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: Back in May 2020, TrialSite…
Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe therapeutics that can treat COVID-19.…
Rural health systems can at times have less access to advanced clinical trials than do urban systems centering on prominent tertiary hospitals and academic medical…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest resources into novel monoclonal antibody-based…
A recent account indicates a successful treatment involving Eli Lilly’s monoclonal antibody treatment for COVID-19, known as bamlanivimab. After receiving an infusion at Mount Sinai…
The National Institutes of Health (NIH) recently updated the COVID-19 Treatment Guidelines: Therapeutic Management of Patients with COVID-19 guidelines highlighting recommended therapeutic treatment by COVID-19…
Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National Institutes of Health (NIH), testing…
A number of media recently reported that the National Institutes of Allergy and Infectious Diseases (NIAID) communicated that government scientists are developing a strain of…
With the COVID-19 pandemic raging, the National Institutes of Health (NIH) announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership to develop a…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
